Antigenic Variant of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019

Wenming Jiang,Guangyu Hou,Jinping Li,Cheng Peng,Suchun Wang,Shuo Liu,Qingye Zhuang,Liping Yuan,Xiaohui Yu,Yang Li,Jingjing Wang,Hualei Liu
DOI: https://doi.org/10.3201/eid2602.191105
IF: 16.126
2020-01-01
Emerging Infectious Diseases
Abstract:In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.
What problem does this paper attempt to address?